Agenus | AGEN - Market Capitalization


Agenus reported $2.94B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 508.97B 46.71B Nov/2026
Agenus USD 128M 21M Mar/2026
Amgen USD 247.94B 20.06B Nov/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Celldex Therapeutics USD 1.88B 669M Nov/2026
CSL USD 55.89B 20.42B Dec/2025
Eli Lilly USD 1.09T 40.33B Sep/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
Glaxosmithkline GBP 101.7B 4.58B Nov/2026
Incyte USD 24.6B 1.95B Sep/2026
J&J USD 653.61B 42.25B Sep/2026
Jiangsu Hengrui CNY 310.59B 1.57B Nov/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
MacroGenics USD 151M 143M Nov/2026
Merck EUR 18.98B 27.8B Jun/2026
Merck USD 375.59B 17.09B Nov/2026
Northwest Biotherapeutics USD 332M 24M Mar/2026
Novartis USD 292.09B 51.5B Sep/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 165.12B 1.71B Nov/2026
Veracyte USD 4.12B 414M Nov/2026